Greg Koblentz, member of the Center’s Scientists Working Group of Chemical and Biological Threats, spoke with Bloomberg about lab safety in BSL-3 and BSL-4 labs. “Nobody wants lab accidents,” said Gregory Koblentz, director of George Mason’s biodefense graduate program and a co-leader of the Global Biolabs project. “Unfortunately this issue has become politicized and polarized. That’s […]
Can a 1975 bioweapons ban handle today’s biothreats?
Greg Koblentz, member of the Center’s Scientists Working Group of Chemical and Biological Threats, was quoted by the Bulletin of the Atomic Scientists on the Biological Weapons Convention. “It is worrisome that states parties can’t agree on relatively simple propositions that would ensure that the Article 1 prohibition on developing biological weapons includes biological agents […]
We’ve Been Talking About the Lab-Leak Hypothesis All Wrong
Greg Koblentz, member of the Center’s Scientists Working Group of Chemical and Biological Threats, spoke with the New York Times about the lab-leak hypothesis and lab safety. “All along, discussion of lab safety has continued, but it’s often been the under-the-radar or behind-the-scenes kind that Filippa Lentzos of King’s College London — one of the leaders, […]
Op-Ed: Biology Is Dangerously Outpacing Policy
Gregory Koblentz, a member of the Center’s Scientists Working Group, co-authored an article for the New York Times about the need for greater government oversight on pathogen research in lab environments. “The original source of the coronavirus pandemic remains unconfirmed. While it was likely the result of a spillover from animals to humans, a lab […]
Expanding the Australia Group’s chemical weapons precursors control list with a family-based approach
Greg Koblentz and Stefano Costanzi, members of the Center’s Scientists Working Group on Biological and Chemical Security, co-authored an article in the journal Pure and Applied Chemistry recommending a family-based approach to controlling the spread of precursors used to make chemical weapons. This article is behind a paywall. Read more